---
document_datetime: 2025-12-18 10:00:10
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/alyftrek-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: alyftrek-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.2536603
conversion_datetime: 2025-12-25 06:08:53.991209
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Alyftrek

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number                    | Scope                                                                                                                                       | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB / EMA/VR/0000315468 | B.II.f.1.b Extension of the shelf life of the finished product - B.II.f.1.b.1 As packaged for sale (supported by real time data) - Accepted | 17/12/2025                          |                                             | SmPC                             |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| Variation type IB / EMA/VR/0000304508   | C.I HUMAN AND VETERINARY MEDICINAL PRODUCTS - C.I.z Other variation - Accepted C.I.z (Type IB) - To update Section 4.4 of the SmPC and Section 2 of the PL to reconcile a discrepancy in the SmPCs for Alyftrek and Kaftrio related to 'Depression and other psychiatric disorders'. In addition, the MAH took the opportunity to implement editorial change to the PI by (1) removing the local representatives in the PL, (2) adding the date of first authorisation and (3) correct translation errors in the FR and DE PI.   | 14/11/2025   |     | SmPC and PL   | To update Section 4.4 of the SmPC and Section 2 of the PL to reconcile a discrepancy in the SmPCs for Alyftrek and Kaftrio related to 'Depression and other psychiatric disorders'. In addition, the MAH took the opportunity to implement editorial change to the PI by (1) removing the local representatives in the PL, (2) adding the date of first authorisation and (3) correct translation errors in the FR and DE PI.   |
|-----------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-----|---------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IB / EMA/VR/0000302870   | C.I HUMAN AND VETERINARY MEDICINAL PRODUCTS - C.I.z Other variation - Accepted To provide the initial study OECD 308 (VX- 121-TX-035: Aerobic Transformation of VX- 121 in Aquatic Sediment Systems at 12Â°C) and interim updated VX-121 Environmental Risk Assessment (ERA) reports.                                                                                                                                                                                                                                             | 30/10/2025   | N/A |               |                                                                                                                                                                                                                                                                                                                                                                                                                                 |